A. J. C. Bune

469 total citations
18 papers, 367 citations indexed

About

A. J. C. Bune is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, A. J. C. Bune has authored 18 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Pharmacology. Recurrent topics in A. J. C. Bune's work include Blood Pressure and Hypertension Studies (8 papers), Hormonal Regulation and Hypertension (7 papers) and Inflammatory mediators and NSAID effects (2 papers). A. J. C. Bune is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Hormonal Regulation and Hypertension (7 papers) and Inflammatory mediators and NSAID effects (2 papers). A. J. C. Bune collaborates with scholars based in Australia, India and Israel. A. J. C. Bune's co-authors include John Chalmers, L. M. H. Wing, Malcolm West, John R. Graham, Peter R.C. Howe, Jonathan M. Hodgson, Geoffrey A. Head, Lawrence J. Beilin, Katherine A. Duggan and Barry P. McGrath and has published in prestigious journals such as Drugs, The Medical Journal of Australia and European Journal of Clinical Pharmacology.

In The Last Decade

A. J. C. Bune

18 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. J. C. Bune Australia 10 219 92 71 60 48 18 367
T. O. Morgan Australia 10 211 1.0× 94 1.0× 66 0.9× 45 0.8× 41 0.9× 26 461
F. Arzilli Italy 11 238 1.1× 78 0.8× 107 1.5× 45 0.8× 55 1.1× 41 404
Adrianne Anderson Australia 13 244 1.1× 61 0.7× 85 1.2× 63 1.1× 22 0.5× 18 358
W Vetter Switzerland 10 159 0.7× 43 0.5× 43 0.6× 82 1.4× 28 0.6× 25 377
J C Petrie United Kingdom 14 179 0.8× 68 0.7× 62 0.9× 64 1.1× 18 0.4× 32 448
JC Petrie United Kingdom 12 189 0.9× 66 0.7× 61 0.9× 57 0.9× 18 0.4× 28 373
R Herings Netherlands 5 163 0.7× 96 1.0× 48 0.7× 32 0.5× 21 0.4× 10 392
P Lund‐Johansen Norway 13 348 1.6× 39 0.4× 87 1.2× 82 1.4× 23 0.5× 31 488
F. Pamparana Italy 12 228 1.0× 64 0.7× 101 1.4× 99 1.6× 40 0.8× 30 580
T A Jeffers United Kingdom 13 270 1.2× 41 0.4× 57 0.8× 88 1.5× 13 0.3× 27 428

Countries citing papers authored by A. J. C. Bune

Since Specialization
Citations

This map shows the geographic impact of A. J. C. Bune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. C. Bune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. C. Bune more than expected).

Fields of papers citing papers by A. J. C. Bune

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. C. Bune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. C. Bune. The network helps show where A. J. C. Bune may publish in the future.

Co-authorship network of co-authors of A. J. C. Bune

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. C. Bune. A scholar is included among the top collaborators of A. J. C. Bune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. C. Bune. A. J. C. Bune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Head, Geoffrey A., Anastasia S. Mihailidou, Katherine A. Duggan, et al.. (2010). Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ. 340(apr14 3). c1104–c1104. 134 indexed citations
2.
Bengzon, Johan, et al.. (2003). C-reactive protein levels following standard neurosurgical procedures. Acta Neurochirurgica. 145(8). 667–671. 18 indexed citations
3.
Russell, Andrew E., Anne Tonkin, L. M. H. Wing, et al.. (1989). ACCURACY OF THE TAKEDA TM‐2420 AMBULATORY BLOOD PRESSURE MONITOR. Clinical and Experimental Pharmacology and Physiology. 16(4). 253–256. 5 indexed citations
4.
Wing, L. M. H., John Chalmers, Malcolm West, A. J. C. Bune, & Andrew E. Russell. (1987). Felodipine Monotherapy in Systolic Hypertension in the Elderly. Drugs. 34(Supplement 3). 194–197. 5 indexed citations
5.
Wing, L. M. H., John Chalmers, A. J. C. Bune, et al.. (1987). Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions.. PubMed. 5(5). S603–6. 9 indexed citations
6.
Chalmers, John, L. M. H. Wing, Malcolm West, et al.. (1986). EFFECTS OF ENALAPRIL AND HYDROCHLOROTHIAZIDE ON BLOOD PRESSURE, RENIN–ANGIOTENSIN SYSTEM, AND ATRIAL NATRIURETIC FACTOR IN ESSENTIAL HYPERTENSION: A DOUBLE BLIND FACTORIAL CROSS‐OVER STUDY. Australian and New Zealand Journal of Medicine. 16(4). 475–480. 26 indexed citations
7.
Wing, L. M. H., et al.. (1985). Slow-Release Nifedipine as a Single or Additional Agent in the Treatment of Essential Hypertension—A Placebo-Controlled Crossover Study. Clinical and Experimental Hypertension Part A Theory and Practice. 7(8). 1173–1185. 4 indexed citations
8.
Wing, L. M. H., et al.. (1985). Effect of Ketanserin on Blood Pressure and Biochemical Parameters in Patients with Essential Hypertension. Journal of Cardiovascular Pharmacology. 7. 164–167. 11 indexed citations
9.
Wing, L. M. H., et al.. (1984). The Effect of Ketanserin on Blood Pressure and Biochemical Parameters in Treated Patients with Essential Hypertension. Clinical and Experimental Hypertension Part A Theory and Practice. 6(6). 1107–1117. 10 indexed citations
10.
Chalmers, John, Malcolm West, L. M. H. Wing, A. J. C. Bune, & John R. Graham. (1984). Effects of Indomethacin, Sulindac, Naproxen, Aspirin, and Paracetamol in Treated Hypertensive Patients. Clinical and Experimental Hypertension Part A Theory and Practice. 6(6). 1077–1093. 67 indexed citations
11.
Chalmers, John, L. M. H. Wing, John J. Grygiel, et al.. (1982). Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting. European Journal of Clinical Pharmacology. 22(3). 191–196. 20 indexed citations
12.
Chalmers, John, A. J. C. Bune, John R. Graham, Malcolm West, & Lindon Wing. (1981). COMPARISON OF INDAPAMIDE WITH THIAZIDE DIURETICS IN PATIENTS WITH ESSENTIAL HYPERTENSION. The Medical Journal of Australia. 2(2). 100–101. 3 indexed citations
13.
Wing, L. M. H., A. J. C. Bune, John Chalmers, John R. Graham, & Malcolm West. (1981). THE EFFECTS OF INDOMETHACIN IN TREATED HYPERTENSIVE PATIENTS. Clinical and Experimental Pharmacology and Physiology. 8(5). 537–541. 22 indexed citations
14.
Bune, A. J. C., John Chalmers, John R. Graham, et al.. (1981). Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension. European Journal of Clinical Pharmacology. 19(5). 309–315. 6 indexed citations
15.
Dargie, H. J., et al.. (1979). Reduction of beta-blocking drugs in hypertensive patients treated with minoxidil.. BMJ. 1(6175). 1400–1400. 5 indexed citations
16.
17.
Bune, A. J. C., et al.. (1975). A double blind factorial trial of pindolol and hydrochlorothiazide in hypertension. Clinical and Experimental Pharmacology and Physiology. 2(5). 446–447. 5 indexed citations
18.
Chalmers, John, et al.. (1962). DOUBLE‐BLIND FACTORIAL TRIAL OF PRINDOLOL AND HYDROCHLOROTHIAZIDE IN HYPERTENSION. The Medical Journal of Australia. 1(18). 650–653. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. O. Morgan Breakdown of academic impact, for papers by F. Arzilli Breakdown of academic impact, for papers by Adrianne Anderson Breakdown of academic impact, for papers by W Vetter Breakdown of academic impact, for papers by J C Petrie Breakdown of academic impact, for papers by JC Petrie Breakdown of academic impact, for papers by R Herings Breakdown of academic impact, for papers by P Lund‐Johansen Breakdown of academic impact, for papers by F. Pamparana Breakdown of academic impact, for papers by T A Jeffers
Rankless by CCL
2026